:: OIPA Home :: UCLA Home :: Collaboration Newsletter ::  

http://www.research.ucla.edu/tech/lifesciences.htm

LATEST ADDITIONS TO THIS PAGE

NEW! Receive by email future UCLA technology licensing opportunities from Biotech and Life/Health Sciences... SUBSCRIBE TO UCLA LifeSci/Biotech Technologies Links to Subcategories Therapeutics - Diagnostics - Imaging - BioInformatics BioReagents/Rsch Tools - Medical Devices - Plant Sciences

2004-351 Reagents to Induce and Quantitate Notch Signal Transduction in Mammalian Cells

2004-274 Immunoneutralizing Monoclonal Antibodies to Rat Alpha-CGRP

2004-275 A MXXXL Motif Confering Endocytosis of Biomolecules

2004-194 YY1: Novel Prognostic Factor in Human Prostate Cancer

2004-192 New SGLT PET Tracers to Monitor Glucose Transport and Metabolism

2004-191 Genetic Risk Marker for Alzheimer's Disease (AD) and Frontotemporal Dementia (FTD)

2004-110 An Integrated Tattoo Removal System

2004-099 Artificial Human Mutation Controls for Clinical Diagnostic Genetic and Proficiency Testing

2004-098 Bacterial Growth Media Derived from Non-mammalian Components

2004-096 Identification of the First Human Glucose Sensor—A New Target for Treatment of Diabetes, Obesity, and Related Metabolic Disorders

2004-073 Murine PTEN Null Prostate Cancer Model

2004-046 Improved Tuberculosis Vaccination Strategy Utilizing a Booster Protein for People Vaccinated with BCG

2003-450 Phospho-Specific Antibody for CaM Kinase II

2003-430 Mouse Model Describing a Novel Hedgehog Pathway Interaction in Medulloblastoma

2003-314 Method to Assemble an Eukaryotic Capsule-like Organelle In-situ and using it to Encapsulate Biomolecules (Proteins, Peptides, Biosensors), to Sequester Toxins and Contaminants, and in Other Nano-Electrical Machine (NEMS) Applications

2003-195 Clinical Tool for Determining Anti-Aggregation Activity of Alzheimer's Therapeutics

2003-190 Medium Formula for Inducing Neural Stem Cells into Oligodendrocytes (OL)

2003-189 Liver X Receptor (LXR) Ligands as Treatments for Type II Diabetes, Obesity and Related Disorders

2003-188 Liver X Receptor (LXR) Agonists as Anti-Inflammatory Agents in Macrophage-Dependent Inflammatory Diseases

2003-090 Specific Delivery of Rifampin to Site of Tuberculosis Infection

2003-075 Shape Encoded Particles (SEPS) for Use in Solution Arrays and Decoding Software

2003-053 Genetically Engineered Mouse Lacking Tumor Suppressor Gene in the Brain

2003-051 Vaccination Against Tumor-Associated Herpesviruses

2002-500 Single Cell Nano-mechanical Stethoscope

2002-491

Cloned Zebrafish from Long-term Cultured Cells

2002-483 Novel Signaling Molecule Utilized By S. Mutans for Bio-film Formation and Quorum Sensing

2002-479 New Treatment Strategy for Gamma-herpes Virus Associated Malignancies Using Inhibitors of the NF-KB Pathway

2002-475 Serum-Free Culture Medium for Maintaining and Propagating Neural Stem Cells (NSCs)

2002-463 Method for Using Carbonic Anhydrase IX as a Molecular Marker for Predicting Survival in Advanced Renal Clear Cell Carcinoma

2002-428 Polyphenolic Compounds Inhibit Pancreatic Cancer

2002-427 Curcumin as a Treatment for Pancreatitis

2002-426 Rapid Assay for Quantification of Intracellular ATM Gene Products

2002-422 A Method to Induce Anti-Viral Responses

2002-358 Conjugated Nanoparticles for Targeted Drug Delivery

2002-274 TCL1 Transgenic Mice

2002-258 A Novel Treatment for Bone Cells that Results in Increased Bone Formation

2002-255 Method and System for Selecting and Designing Eyeglass Frames

2002-222 Coated Filter for Growing Reusable Organotypic Tissue Slices

2002-207 NA,K-ATPASE α AND β -Subunits as Tumor Markers for Diagnosis and Prognosis of Bladder Cancer

2002-185 Prophylactic and Chemotherapeutic Method for Treating Tuberculosis

2002-135 C-MYC Transgenic Mouse

2002-133 Use of a Gene and Related Mouse Model for the Study and Development of Therapeutics for Neuropsychiatric Disorders

2002-004 Vector for Tissue Specific Amplification of Both Reporter and Therapeutic Genes

2001-466 Pituitary Adenylyl Cyclase-Activating Peptide (PACAP) Deficient Mice

2001-432 Single Molecule Detection of DNA Hybridization Using Detection of Probe Conformation

2001-425 Receptor Interacting Protein 2 (RIP2) in Development of Immune Response

2001-411 High-Density Electrodes for Neural Stimulation

2001-381 Use of Secondary Lymphoid Organ Chemokine to Induce Anti-tumor Response by Stimulating Cell-mediated Immune Response and Inhibiting Angiogenesis

2001-329 Retrocyclin: an Anti-Retroviral Circular Minidefensin

2001-194 Wit 3.0, a Novel Gene to Control Soft Tissue Wound Healing

2001-173 Vasoactive Intestinal Peptide (VIP) and Peptide Histidine Isoleucine (PHI) Knockout Mice

2000-499 Electronics Integrated with Bio-Reactor Channel for Detection or Fabrication of Bio-Materials

2000-490 Method of Recording Electroencephalographic Signals Simultaneously with Functional MRI

2000-479 GDOX, A Novel Candidate Proto-oncogene

2000-459 Gastrointestinal Chemosensory Receptors and In Vitro Screening System for Screening of Associated Ligands

2000-377 Live Recombinant Tuberculosis Vaccine

2000-236 Granulin as a Target for Tumor Diagnosis and Growth Regulation

2000-203 Anti-Sense Oligonucleotide Targeted Prophylactic and Chemotherapeutic Agent Against Mycobacterium Tuberculosis

2000-128 Targeting Lentiviral Vectors to Specific Cells and Tissues

2000-044 Universal Vectors for Drug Delivery

1997-505 A Protein of Mycobacterium Tuberculosis Stimulates Interleukin-12 Production

:: OIP Home Page

The Office of Intellectual Property (OIP) manages a campus-wide patent and invention portfolio resulting from UCLA research funded by more than $750 million per year in federal, state and private contracts and grants.

Contact information:

Office of Intellectual Property
11000 Kinross Ave., Suite 200
Los Angeles, CA 90095-1406
Tel. 310.794.0558

http://www.research.ucla.edu/oip

:: UCLA Lab Directory

:: UCLA Research Interests
:: Collaboration Newsletter